Committed to sharing our science

Committed to sharing our science

374 results available

Long-term Impact of Aficamten on Patient-Reported Outcome Measures in Obstructive Hypertrophic Cardiomyopathy: Results From FOREST-HCM

Oral Presentation, HCMS 2025

Weiner, S et al.

November 7, 2025
Evaluation of the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Aficamten in Healthy Japanese and Caucasian Participants

Poster, ACCP 2025

Xu, D et al.

September 14, 2025
Pharmacokinetics, Excretion, and Metabolism of [14C]CK-4021586 Following Single Oral Administration to Rats

Poster, ISSX 2025

Grillo, MP et al.

September 21, 2025
Characterization and Application of Novel Exercise Recovery Patterns That Reflect Cardiac Performance: A Substudy of the SEQUOIA-HCM Trial

Circulation

Campain, J et al.

September 5, 2025
Safety and Efficacy of Aficamten in Patients With Nonobstructive Hypertrophic Cardiomyopathy: A 96-Week Analysis From FOREST-HCM

Journal of Cardiac Failure

Masri, A et al.

September 28, 2025